人工多能性幹細胞製造装置の世界市場インサイト・予測(~2028年)

◆英語タイトル:Global Induced Pluripotent Stem Cells Production Market Insights and Forecast to 2028

QYResearchが発行した調査報告書(QY22MA00001)◆商品コード:QY22MA00001
◆発行会社(リサーチ会社):QYResearch
◆発行日:2022年3月
◆ページ数:106
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

新型コロナウイルス感染症のパンデミックにより、世界の人工多能性幹細胞製造装置の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に人工多能性幹細胞製造装置の世界市場のxxx%を占める「肝細胞」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「学術研究」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
中国の人工多能性幹細胞製造装置の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの人工多能性幹細胞製造装置市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパの人工多能性幹細胞製造装置市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

人工多能性幹細胞製造装置のグローバル主要メーカーには、Lonza、Axol Bioscience Ltd.、Evotec、Hitachi Ltd.、Merck KGaA、REPROCELL Inc.、Fate Therapeutics、Thermo Fisher Scientific, Inc.、StemCellFactory III、Applied StemCell Inc.などがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

人工多能性幹細胞製造装置市場は、種類と用途によって区分されます。世界の人工多能性幹細胞製造装置市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
肝細胞、線維芽細胞、ケラチノサイト、羊水細胞、その他

【用途別セグメント】
学術研究、創薬、毒性スクリーニング、再生医療

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- 人工多能性幹細胞製造装置製品概要
- 種類別市場(肝細胞、線維芽細胞、ケラチノサイト、羊水細胞、その他)
- 用途別市場(学術研究、創薬、毒性スクリーニング、再生医療)
- 調査の目的
・エグゼクティブサマリー
- 世界の人工多能性幹細胞製造装置販売量予測2017-2028
- 世界の人工多能性幹細胞製造装置売上予測2017-2028
- 人工多能性幹細胞製造装置の地域別販売量
- 人工多能性幹細胞製造装置の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別人工多能性幹細胞製造装置販売量
- 主要メーカー別人工多能性幹細胞製造装置売上
- 主要メーカー別人工多能性幹細胞製造装置価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(肝細胞、線維芽細胞、ケラチノサイト、羊水細胞、その他)
- 人工多能性幹細胞製造装置の種類別販売量
- 人工多能性幹細胞製造装置の種類別売上
- 人工多能性幹細胞製造装置の種類別価格
・用途別市場規模(学術研究、創薬、毒性スクリーニング、再生医療)
- 人工多能性幹細胞製造装置の用途別販売量
- 人工多能性幹細胞製造装置の用途別売上
- 人工多能性幹細胞製造装置の用途別価格
・北米市場
- 北米の人工多能性幹細胞製造装置市場規模(種類別、用途別)
- 主要国別の人工多能性幹細胞製造装置市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパの人工多能性幹細胞製造装置市場規模(種類別、用途別)
- 主要国別の人工多能性幹細胞製造装置市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋の人工多能性幹細胞製造装置市場規模(種類別、用途別)
- 主要国別の人工多能性幹細胞製造装置市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米の人工多能性幹細胞製造装置市場規模(種類別、用途別)
- 主要国別の人工多能性幹細胞製造装置市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカの人工多能性幹細胞製造装置市場規模(種類別、用途別)
- 主要国別の人工多能性幹細胞製造装置市場規模(トルコ、サウジアラビア)
・企業情報
Lonza、Axol Bioscience Ltd.、Evotec、Hitachi Ltd.、Merck KGaA、REPROCELL Inc.、Fate Therapeutics、Thermo Fisher Scientific, Inc.、StemCellFactory III、Applied StemCell Inc.
・産業チェーン及び販売チャネル分析
- 人工多能性幹細胞製造装置の産業チェーン分析
- 人工多能性幹細胞製造装置の原材料
- 人工多能性幹細胞製造装置の生産プロセス
- 人工多能性幹細胞製造装置の販売及びマーケティング
- 人工多能性幹細胞製造装置の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 人工多能性幹細胞製造装置の産業動向
- 人工多能性幹細胞製造装置のマーケットドライバー
- 人工多能性幹細胞製造装置の課題
- 人工多能性幹細胞製造装置の阻害要因
・主な調査結果

Induced Pluripotent Stem Cells (iPSC) are generated from skin or blood cells that have been reprogrammed into an embryonic-like pluripotent state, allowing to produce an infinite source of any kind of human cell required for therapeutic reasons.
Market Analysis and Insights: Global Induced Pluripotent Stem Cells Production Market
Due to the COVID-19 pandemic, the global Induced Pluripotent Stem Cells Production market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Hepatocytes accounting for % of the Induced Pluripotent Stem Cells Production global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Academic Research segment is altered to an % CAGR throughout this forecast period.
China Induced Pluripotent Stem Cells Production market size is valued at US$ million in 2021, while the US and Europe Induced Pluripotent Stem Cells Production are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Induced Pluripotent Stem Cells Production landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Induced Pluripotent Stem Cells Production include Lonza, Axol Bioscience Ltd., Evotec, Hitachi Ltd., Merck KGaA, REPROCELL Inc., Fate Therapeutics, Thermo Fisher Scientific, Inc. and StemCellFactory III and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Induced Pluripotent Stem Cells Production Scope and Segment
Induced Pluripotent Stem Cells Production market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Induced Pluripotent Stem Cells Production market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Hepatocytes
Fibroblasts
Keratinocytes
Amniotic Cells
Others
Segment by Application
Academic Research
Drug Development
Toxicity Screening
Regenerative Medicine
By Company
Lonza
Axol Bioscience Ltd.
Evotec
Hitachi Ltd.
Merck KGaA
REPROCELL Inc.
Fate Therapeutics
Thermo Fisher Scientific, Inc.
StemCellFactory III
Applied StemCell Inc.
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Induced Pluripotent Stem Cells Production Product Introduction
1.2 Market by Type
1.2.1 Global Induced Pluripotent Stem Cells Production Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Hepatocytes
1.2.3 Fibroblasts
1.2.4 Keratinocytes
1.2.5 Amniotic Cells
1.2.6 Others
1.3 Market by Application
1.3.1 Global Induced Pluripotent Stem Cells Production Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Academic Research
1.3.3 Drug Development
1.3.4 Toxicity Screening
1.3.5 Regenerative Medicine
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Induced Pluripotent Stem Cells Production Sales Estimates and Forecasts 2017-2028
2.2 Global Induced Pluripotent Stem Cells Production Revenue Estimates and Forecasts 2017-2028
2.3 Global Induced Pluripotent Stem Cells Production Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Induced Pluripotent Stem Cells Production Sales by Region
2.4.1 Global Induced Pluripotent Stem Cells Production Sales by Region (2017-2022)
2.4.2 Global Sales Induced Pluripotent Stem Cells Production by Region (2023-2028)
2.5 Global Induced Pluripotent Stem Cells Production Revenue by Region
2.5.1 Global Induced Pluripotent Stem Cells Production Revenue by Region (2017-2022)
2.5.2 Global Induced Pluripotent Stem Cells Production Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Induced Pluripotent Stem Cells Production Sales by Manufacturers
3.1.1 Global Top Induced Pluripotent Stem Cells Production Manufacturers by Sales (2017-2022)
3.1.2 Global Induced Pluripotent Stem Cells Production Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Induced Pluripotent Stem Cells Production in 2021
3.2 Global Induced Pluripotent Stem Cells Production Revenue by Manufacturers
3.2.1 Global Induced Pluripotent Stem Cells Production Revenue by Manufacturers (2017-2022)
3.2.2 Global Induced Pluripotent Stem Cells Production Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Induced Pluripotent Stem Cells Production Revenue in 2021
3.3 Global Induced Pluripotent Stem Cells Production Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Induced Pluripotent Stem Cells Production Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Induced Pluripotent Stem Cells Production Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Induced Pluripotent Stem Cells Production Sales by Type
4.1.1 Global Induced Pluripotent Stem Cells Production Historical Sales by Type (2017-2022)
4.1.2 Global Induced Pluripotent Stem Cells Production Forecasted Sales by Type (2023-2028)
4.1.3 Global Induced Pluripotent Stem Cells Production Sales Market Share by Type (2017-2028)
4.2 Global Induced Pluripotent Stem Cells Production Revenue by Type
4.2.1 Global Induced Pluripotent Stem Cells Production Historical Revenue by Type (2017-2022)
4.2.2 Global Induced Pluripotent Stem Cells Production Forecasted Revenue by Type (2023-2028)
4.2.3 Global Induced Pluripotent Stem Cells Production Revenue Market Share by Type (2017-2028)
4.3 Global Induced Pluripotent Stem Cells Production Price by Type
4.3.1 Global Induced Pluripotent Stem Cells Production Price by Type (2017-2022)
4.3.2 Global Induced Pluripotent Stem Cells Production Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Induced Pluripotent Stem Cells Production Sales by Application
5.1.1 Global Induced Pluripotent Stem Cells Production Historical Sales by Application (2017-2022)
5.1.2 Global Induced Pluripotent Stem Cells Production Forecasted Sales by Application (2023-2028)
5.1.3 Global Induced Pluripotent Stem Cells Production Sales Market Share by Application (2017-2028)
5.2 Global Induced Pluripotent Stem Cells Production Revenue by Application
5.2.1 Global Induced Pluripotent Stem Cells Production Historical Revenue by Application (2017-2022)
5.2.2 Global Induced Pluripotent Stem Cells Production Forecasted Revenue by Application (2023-2028)
5.2.3 Global Induced Pluripotent Stem Cells Production Revenue Market Share by Application (2017-2028)
5.3 Global Induced Pluripotent Stem Cells Production Price by Application
5.3.1 Global Induced Pluripotent Stem Cells Production Price by Application (2017-2022)
5.3.2 Global Induced Pluripotent Stem Cells Production Price Forecast by Application (2023-2028)
6 North America
6.1 North America Induced Pluripotent Stem Cells Production Market Size by Type
6.1.1 North America Induced Pluripotent Stem Cells Production Sales by Type (2017-2028)
6.1.2 North America Induced Pluripotent Stem Cells Production Revenue by Type (2017-2028)
6.2 North America Induced Pluripotent Stem Cells Production Market Size by Application
6.2.1 North America Induced Pluripotent Stem Cells Production Sales by Application (2017-2028)
6.2.2 North America Induced Pluripotent Stem Cells Production Revenue by Application (2017-2028)
6.3 North America Induced Pluripotent Stem Cells Production Market Size by Country
6.3.1 North America Induced Pluripotent Stem Cells Production Sales by Country (2017-2028)
6.3.2 North America Induced Pluripotent Stem Cells Production Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Induced Pluripotent Stem Cells Production Market Size by Type
7.1.1 Europe Induced Pluripotent Stem Cells Production Sales by Type (2017-2028)
7.1.2 Europe Induced Pluripotent Stem Cells Production Revenue by Type (2017-2028)
7.2 Europe Induced Pluripotent Stem Cells Production Market Size by Application
7.2.1 Europe Induced Pluripotent Stem Cells Production Sales by Application (2017-2028)
7.2.2 Europe Induced Pluripotent Stem Cells Production Revenue by Application (2017-2028)
7.3 Europe Induced Pluripotent Stem Cells Production Market Size by Country
7.3.1 Europe Induced Pluripotent Stem Cells Production Sales by Country (2017-2028)
7.3.2 Europe Induced Pluripotent Stem Cells Production Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Induced Pluripotent Stem Cells Production Market Size by Type
8.1.1 Asia Pacific Induced Pluripotent Stem Cells Production Sales by Type (2017-2028)
8.1.2 Asia Pacific Induced Pluripotent Stem Cells Production Revenue by Type (2017-2028)
8.2 Asia Pacific Induced Pluripotent Stem Cells Production Market Size by Application
8.2.1 Asia Pacific Induced Pluripotent Stem Cells Production Sales by Application (2017-2028)
8.2.2 Asia Pacific Induced Pluripotent Stem Cells Production Revenue by Application (2017-2028)
8.3 Asia Pacific Induced Pluripotent Stem Cells Production Market Size by Region
8.3.1 Asia Pacific Induced Pluripotent Stem Cells Production Sales by Region (2017-2028)
8.3.2 Asia Pacific Induced Pluripotent Stem Cells Production Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Induced Pluripotent Stem Cells Production Market Size by Type
9.1.1 Latin America Induced Pluripotent Stem Cells Production Sales by Type (2017-2028)
9.1.2 Latin America Induced Pluripotent Stem Cells Production Revenue by Type (2017-2028)
9.2 Latin America Induced Pluripotent Stem Cells Production Market Size by Application
9.2.1 Latin America Induced Pluripotent Stem Cells Production Sales by Application (2017-2028)
9.2.2 Latin America Induced Pluripotent Stem Cells Production Revenue by Application (2017-2028)
9.3 Latin America Induced Pluripotent Stem Cells Production Market Size by Country
9.3.1 Latin America Induced Pluripotent Stem Cells Production Sales by Country (2017-2028)
9.3.2 Latin America Induced Pluripotent Stem Cells Production Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Induced Pluripotent Stem Cells Production Market Size by Type
10.1.1 Middle East and Africa Induced Pluripotent Stem Cells Production Sales by Type (2017-2028)
10.1.2 Middle East and Africa Induced Pluripotent Stem Cells Production Revenue by Type (2017-2028)
10.2 Middle East and Africa Induced Pluripotent Stem Cells Production Market Size by Application
10.2.1 Middle East and Africa Induced Pluripotent Stem Cells Production Sales by Application (2017-2028)
10.2.2 Middle East and Africa Induced Pluripotent Stem Cells Production Revenue by Application (2017-2028)
10.3 Middle East and Africa Induced Pluripotent Stem Cells Production Market Size by Country
10.3.1 Middle East and Africa Induced Pluripotent Stem Cells Production Sales by Country (2017-2028)
10.3.2 Middle East and Africa Induced Pluripotent Stem Cells Production Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Lonza
11.1.1 Lonza Corporation Information
11.1.2 Lonza Overview
11.1.3 Lonza Induced Pluripotent Stem Cells Production Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Lonza Induced Pluripotent Stem Cells Production Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Lonza Recent Developments
11.2 Axol Bioscience Ltd.
11.2.1 Axol Bioscience Ltd. Corporation Information
11.2.2 Axol Bioscience Ltd. Overview
11.2.3 Axol Bioscience Ltd. Induced Pluripotent Stem Cells Production Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Axol Bioscience Ltd. Induced Pluripotent Stem Cells Production Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Axol Bioscience Ltd. Recent Developments
11.3 Evotec
11.3.1 Evotec Corporation Information
11.3.2 Evotec Overview
11.3.3 Evotec Induced Pluripotent Stem Cells Production Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Evotec Induced Pluripotent Stem Cells Production Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Evotec Recent Developments
11.4 Hitachi Ltd.
11.4.1 Hitachi Ltd. Corporation Information
11.4.2 Hitachi Ltd. Overview
11.4.3 Hitachi Ltd. Induced Pluripotent Stem Cells Production Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Hitachi Ltd. Induced Pluripotent Stem Cells Production Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Hitachi Ltd. Recent Developments
11.5 Merck KGaA
11.5.1 Merck KGaA Corporation Information
11.5.2 Merck KGaA Overview
11.5.3 Merck KGaA Induced Pluripotent Stem Cells Production Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Merck KGaA Induced Pluripotent Stem Cells Production Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Merck KGaA Recent Developments
11.6 REPROCELL Inc.
11.6.1 REPROCELL Inc. Corporation Information
11.6.2 REPROCELL Inc. Overview
11.6.3 REPROCELL Inc. Induced Pluripotent Stem Cells Production Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 REPROCELL Inc. Induced Pluripotent Stem Cells Production Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 REPROCELL Inc. Recent Developments
11.7 Fate Therapeutics
11.7.1 Fate Therapeutics Corporation Information
11.7.2 Fate Therapeutics Overview
11.7.3 Fate Therapeutics Induced Pluripotent Stem Cells Production Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Fate Therapeutics Induced Pluripotent Stem Cells Production Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Fate Therapeutics Recent Developments
11.8 Thermo Fisher Scientific, Inc.
11.8.1 Thermo Fisher Scientific, Inc. Corporation Information
11.8.2 Thermo Fisher Scientific, Inc. Overview
11.8.3 Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells Production Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells Production Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Thermo Fisher Scientific, Inc. Recent Developments
11.9 StemCellFactory III
11.9.1 StemCellFactory III Corporation Information
11.9.2 StemCellFactory III Overview
11.9.3 StemCellFactory III Induced Pluripotent Stem Cells Production Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 StemCellFactory III Induced Pluripotent Stem Cells Production Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 StemCellFactory III Recent Developments
11.10 Applied StemCell Inc.
11.10.1 Applied StemCell Inc. Corporation Information
11.10.2 Applied StemCell Inc. Overview
11.10.3 Applied StemCell Inc. Induced Pluripotent Stem Cells Production Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Applied StemCell Inc. Induced Pluripotent Stem Cells Production Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Applied StemCell Inc. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Induced Pluripotent Stem Cells Production Industry Chain Analysis
12.2 Induced Pluripotent Stem Cells Production Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Induced Pluripotent Stem Cells Production Production Mode & Process
12.4 Induced Pluripotent Stem Cells Production Sales and Marketing
12.4.1 Induced Pluripotent Stem Cells Production Sales Channels
12.4.2 Induced Pluripotent Stem Cells Production Distributors
12.5 Induced Pluripotent Stem Cells Production Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Induced Pluripotent Stem Cells Production Industry Trends
13.2 Induced Pluripotent Stem Cells Production Market Drivers
13.3 Induced Pluripotent Stem Cells Production Market Challenges
13.4 Induced Pluripotent Stem Cells Production Market Restraints
14 Key Findings in The Global Induced Pluripotent Stem Cells Production Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Induced Pluripotent Stem Cells Production Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Hepatocytes
Table 3. Major Manufacturers of Fibroblasts
Table 4. Major Manufacturers of Keratinocytes
Table 5. Major Manufacturers of Amniotic Cells
Table 6. Major Manufacturers of Others
Table 7. Global Induced Pluripotent Stem Cells Production Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Induced Pluripotent Stem Cells Production Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Induced Pluripotent Stem Cells Production Sales by Region (2017-2022) & (K Units)
Table 10. Global Induced Pluripotent Stem Cells Production Sales Market Share by Region (2017-2022)
Table 11. Global Induced Pluripotent Stem Cells Production Sales by Region (2023-2028) & (K Units)
Table 12. Global Induced Pluripotent Stem Cells Production Sales Market Share by Region (2023-2028)
Table 13. Global Induced Pluripotent Stem Cells Production Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Induced Pluripotent Stem Cells Production Revenue Market Share by Region (2017-2022)
Table 15. Global Induced Pluripotent Stem Cells Production Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Induced Pluripotent Stem Cells Production Revenue Market Share by Region (2023-2028)
Table 17. Global Induced Pluripotent Stem Cells Production Sales by Manufacturers (2017-2022) & (K Units)
Table 18. Global Induced Pluripotent Stem Cells Production Sales Share by Manufacturers (2017-2022)
Table 19. Global Induced Pluripotent Stem Cells Production Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Induced Pluripotent Stem Cells Production Revenue Share by Manufacturers (2017-2022)
Table 21. Induced Pluripotent Stem Cells Production Price by Manufacturers (2017-2022) &(US$/Unit)
Table 22. Global Induced Pluripotent Stem Cells Production Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Induced Pluripotent Stem Cells Production by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Induced Pluripotent Stem Cells Production as of 2021)
Table 24. Induced Pluripotent Stem Cells Production Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Induced Pluripotent Stem Cells Production Product Offered
Table 26. Date of Manufacturers Enter into Induced Pluripotent Stem Cells Production Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Induced Pluripotent Stem Cells Production Sales by Type (2017-2022) & (K Units)
Table 29. Global Induced Pluripotent Stem Cells Production Sales by Type (2023-2028) & (K Units)
Table 30. Global Induced Pluripotent Stem Cells Production Sales Share by Type (2017-2022)
Table 31. Global Induced Pluripotent Stem Cells Production Sales Share by Type (2023-2028)
Table 32. Global Induced Pluripotent Stem Cells Production Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Induced Pluripotent Stem Cells Production Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Induced Pluripotent Stem Cells Production Revenue Share by Type (2017-2022)
Table 35. Global Induced Pluripotent Stem Cells Production Revenue Share by Type (2023-2028)
Table 36. Induced Pluripotent Stem Cells Production Price by Type (2017-2022) & (US$/Unit)
Table 37. Global Induced Pluripotent Stem Cells Production Price Forecast by Type (2023-2028) & (US$/Unit)
Table 38. Global Induced Pluripotent Stem Cells Production Sales by Application (2017-2022) & (K Units)
Table 39. Global Induced Pluripotent Stem Cells Production Sales by Application (2023-2028) & (K Units)
Table 40. Global Induced Pluripotent Stem Cells Production Sales Share by Application (2017-2022)
Table 41. Global Induced Pluripotent Stem Cells Production Sales Share by Application (2023-2028)
Table 42. Global Induced Pluripotent Stem Cells Production Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Induced Pluripotent Stem Cells Production Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Induced Pluripotent Stem Cells Production Revenue Share by Application (2017-2022)
Table 45. Global Induced Pluripotent Stem Cells Production Revenue Share by Application (2023-2028)
Table 46. Induced Pluripotent Stem Cells Production Price by Application (2017-2022) & (US$/Unit)
Table 47. Global Induced Pluripotent Stem Cells Production Price Forecast by Application (2023-2028) & (US$/Unit)
Table 48. North America Induced Pluripotent Stem Cells Production Sales by Type (2017-2022) & (K Units)
Table 49. North America Induced Pluripotent Stem Cells Production Sales by Type (2023-2028) & (K Units)
Table 50. North America Induced Pluripotent Stem Cells Production Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Induced Pluripotent Stem Cells Production Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Induced Pluripotent Stem Cells Production Sales by Application (2017-2022) & (K Units)
Table 53. North America Induced Pluripotent Stem Cells Production Sales by Application (2023-2028) & (K Units)
Table 54. North America Induced Pluripotent Stem Cells Production Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Induced Pluripotent Stem Cells Production Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Induced Pluripotent Stem Cells Production Sales by Country (2017-2022) & (K Units)
Table 57. North America Induced Pluripotent Stem Cells Production Sales by Country (2023-2028) & (K Units)
Table 58. North America Induced Pluripotent Stem Cells Production Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Induced Pluripotent Stem Cells Production Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Induced Pluripotent Stem Cells Production Sales by Type (2017-2022) & (K Units)
Table 61. Europe Induced Pluripotent Stem Cells Production Sales by Type (2023-2028) & (K Units)
Table 62. Europe Induced Pluripotent Stem Cells Production Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Induced Pluripotent Stem Cells Production Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Induced Pluripotent Stem Cells Production Sales by Application (2017-2022) & (K Units)
Table 65. Europe Induced Pluripotent Stem Cells Production Sales by Application (2023-2028) & (K Units)
Table 66. Europe Induced Pluripotent Stem Cells Production Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Induced Pluripotent Stem Cells Production Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Induced Pluripotent Stem Cells Production Sales by Country (2017-2022) & (K Units)
Table 69. Europe Induced Pluripotent Stem Cells Production Sales by Country (2023-2028) & (K Units)
Table 70. Europe Induced Pluripotent Stem Cells Production Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Induced Pluripotent Stem Cells Production Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Induced Pluripotent Stem Cells Production Sales by Type (2017-2022) & (K Units)
Table 73. Asia Pacific Induced Pluripotent Stem Cells Production Sales by Type (2023-2028) & (K Units)
Table 74. Asia Pacific Induced Pluripotent Stem Cells Production Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Induced Pluripotent Stem Cells Production Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Induced Pluripotent Stem Cells Production Sales by Application (2017-2022) & (K Units)
Table 77. Asia Pacific Induced Pluripotent Stem Cells Production Sales by Application (2023-2028) & (K Units)
Table 78. Asia Pacific Induced Pluripotent Stem Cells Production Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Induced Pluripotent Stem Cells Production Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Induced Pluripotent Stem Cells Production Sales by Region (2017-2022) & (K Units)
Table 81. Asia Pacific Induced Pluripotent Stem Cells Production Sales by Region (2023-2028) & (K Units)
Table 82. Asia Pacific Induced Pluripotent Stem Cells Production Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Induced Pluripotent Stem Cells Production Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Induced Pluripotent Stem Cells Production Sales by Type (2017-2022) & (K Units)
Table 85. Latin America Induced Pluripotent Stem Cells Production Sales by Type (2023-2028) & (K Units)
Table 86. Latin America Induced Pluripotent Stem Cells Production Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Induced Pluripotent Stem Cells Production Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Induced Pluripotent Stem Cells Production Sales by Application (2017-2022) & (K Units)
Table 89. Latin America Induced Pluripotent Stem Cells Production Sales by Application (2023-2028) & (K Units)
Table 90. Latin America Induced Pluripotent Stem Cells Production Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Induced Pluripotent Stem Cells Production Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Induced Pluripotent Stem Cells Production Sales by Country (2017-2022) & (K Units)
Table 93. Latin America Induced Pluripotent Stem Cells Production Sales by Country (2023-2028) & (K Units)
Table 94. Latin America Induced Pluripotent Stem Cells Production Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Induced Pluripotent Stem Cells Production Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Induced Pluripotent Stem Cells Production Sales by Type (2017-2022) & (K Units)
Table 97. Middle East and Africa Induced Pluripotent Stem Cells Production Sales by Type (2023-2028) & (K Units)
Table 98. Middle East and Africa Induced Pluripotent Stem Cells Production Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Induced Pluripotent Stem Cells Production Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Induced Pluripotent Stem Cells Production Sales by Application (2017-2022) & (K Units)
Table 101. Middle East and Africa Induced Pluripotent Stem Cells Production Sales by Application (2023-2028) & (K Units)
Table 102. Middle East and Africa Induced Pluripotent Stem Cells Production Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Induced Pluripotent Stem Cells Production Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Induced Pluripotent Stem Cells Production Sales by Country (2017-2022) & (K Units)
Table 105. Middle East and Africa Induced Pluripotent Stem Cells Production Sales by Country (2023-2028) & (K Units)
Table 106. Middle East and Africa Induced Pluripotent Stem Cells Production Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Induced Pluripotent Stem Cells Production Revenue by Country (2023-2028) & (US$ Million)
Table 108. Lonza Corporation Information
Table 109. Lonza Description and Major Businesses
Table 110. Lonza Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 111. Lonza Induced Pluripotent Stem Cells Production Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Lonza Recent Developments
Table 113. Axol Bioscience Ltd. Corporation Information
Table 114. Axol Bioscience Ltd. Description and Major Businesses
Table 115. Axol Bioscience Ltd. Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 116. Axol Bioscience Ltd. Induced Pluripotent Stem Cells Production Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Axol Bioscience Ltd. Recent Developments
Table 118. Evotec Corporation Information
Table 119. Evotec Description and Major Businesses
Table 120. Evotec Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 121. Evotec Induced Pluripotent Stem Cells Production Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Evotec Recent Developments
Table 123. Hitachi Ltd. Corporation Information
Table 124. Hitachi Ltd. Description and Major Businesses
Table 125. Hitachi Ltd. Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 126. Hitachi Ltd. Induced Pluripotent Stem Cells Production Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Hitachi Ltd. Recent Developments
Table 128. Merck KGaA Corporation Information
Table 129. Merck KGaA Description and Major Businesses
Table 130. Merck KGaA Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 131. Merck KGaA Induced Pluripotent Stem Cells Production Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Merck KGaA Recent Developments
Table 133. REPROCELL Inc. Corporation Information
Table 134. REPROCELL Inc. Description and Major Businesses
Table 135. REPROCELL Inc. Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 136. REPROCELL Inc. Induced Pluripotent Stem Cells Production Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. REPROCELL Inc. Recent Developments
Table 138. Fate Therapeutics Corporation Information
Table 139. Fate Therapeutics Description and Major Businesses
Table 140. Fate Therapeutics Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 141. Fate Therapeutics Induced Pluripotent Stem Cells Production Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Fate Therapeutics Recent Developments
Table 143. Thermo Fisher Scientific, Inc. Corporation Information
Table 144. Thermo Fisher Scientific, Inc. Description and Major Businesses
Table 145. Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 146. Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells Production Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Thermo Fisher Scientific, Inc. Recent Developments
Table 148. StemCellFactory III Corporation Information
Table 149. StemCellFactory III Description and Major Businesses
Table 150. StemCellFactory III Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 151. StemCellFactory III Induced Pluripotent Stem Cells Production Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. StemCellFactory III Recent Developments
Table 153. Applied StemCell Inc. Corporation Information
Table 154. Applied StemCell Inc. Description and Major Businesses
Table 155. Applied StemCell Inc. Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 156. Applied StemCell Inc. Induced Pluripotent Stem Cells Production Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Applied StemCell Inc. Recent Developments
Table 158. Key Raw Materials Lists
Table 159. Raw Materials Key Suppliers Lists
Table 160. Induced Pluripotent Stem Cells Production Distributors List
Table 161. Induced Pluripotent Stem Cells Production Customers List
Table 162. Induced Pluripotent Stem Cells Production Market Trends
Table 163. Induced Pluripotent Stem Cells Production Market Drivers
Table 164. Induced Pluripotent Stem Cells Production Market Challenges
Table 165. Induced Pluripotent Stem Cells Production Market Restraints
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Induced Pluripotent Stem Cells Production Product Picture
Figure 3. Global Induced Pluripotent Stem Cells Production Market Share by Type in 2021 & 2028
Figure 3. Hepatocytes Product Picture
Figure 4. Fibroblasts Product Picture
Figure 5. Keratinocytes Product Picture
Figure 6. Amniotic Cells Product Picture
Figure 7. Others Product Picture
Figure 8. Global Induced Pluripotent Stem Cells Production Market Share by Application in 2021 & 2028
Figure 9. Academic Research
Figure 10. Drug Development
Figure 11. Toxicity Screening
Figure 12. Regenerative Medicine
Figure 13. Induced Pluripotent Stem Cells Production Report Years Considered
Figure 14. Global Induced Pluripotent Stem Cells Production Sales 2017-2028 (K Units)
Figure 15. Global Induced Pluripotent Stem Cells Production Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Induced Pluripotent Stem Cells Production Revenue 2017-2028 (US$ Million)
Figure 17. Global Induced Pluripotent Stem Cells Production Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 18. Global Induced Pluripotent Stem Cells Production Sales Market Share by Region (2017-2022)
Figure 19. Global Induced Pluripotent Stem Cells Production Sales Market Share by Region (2023-2028)
Figure 20. North America Induced Pluripotent Stem Cells Production Sales YoY (2017-2028) & (K Units)
Figure 21. North America Induced Pluripotent Stem Cells Production Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Europe Induced Pluripotent Stem Cells Production Sales YoY (2017-2028) & (K Units)
Figure 23. Europe Induced Pluripotent Stem Cells Production Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Asia-Pacific Induced Pluripotent Stem Cells Production Sales YoY (2017-2028) & (K Units)
Figure 25. Asia-Pacific Induced Pluripotent Stem Cells Production Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Latin America Induced Pluripotent Stem Cells Production Sales YoY (2017-2028) & (K Units)
Figure 27. Latin America Induced Pluripotent Stem Cells Production Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Middle East & Africa Induced Pluripotent Stem Cells Production Sales YoY (2017-2028) & (K Units)
Figure 29. Middle East & Africa Induced Pluripotent Stem Cells Production Revenue YoY (2017-2028) & (US$ Million)
Figure 30. The Induced Pluripotent Stem Cells Production Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 31. The Top 5 and 10 Largest Manufacturers of Induced Pluripotent Stem Cells Production in the World: Market Share by Induced Pluripotent Stem Cells Production Revenue in 2021
Figure 32. Global Induced Pluripotent Stem Cells Production Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 33. Global Induced Pluripotent Stem Cells Production Sales Market Share by Type (2017-2028)
Figure 34. Global Induced Pluripotent Stem Cells Production Revenue Market Share by Type (2017-2028)
Figure 35. Global Induced Pluripotent Stem Cells Production Sales Market Share by Application (2017-2028)
Figure 36. Global Induced Pluripotent Stem Cells Production Revenue Market Share by Application (2017-2028)
Figure 37. North America Induced Pluripotent Stem Cells Production Sales Market Share by Type (2017-2028)
Figure 38. North America Induced Pluripotent Stem Cells Production Revenue Market Share by Type (2017-2028)
Figure 39. North America Induced Pluripotent Stem Cells Production Sales Market Share by Application (2017-2028)
Figure 40. North America Induced Pluripotent Stem Cells Production Revenue Market Share by Application (2017-2028)
Figure 41. North America Induced Pluripotent Stem Cells Production Sales Share by Country (2017-2028)
Figure 42. North America Induced Pluripotent Stem Cells Production Revenue Share by Country (2017-2028)
Figure 43. United States Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 44. Canada Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 45. Europe Induced Pluripotent Stem Cells Production Sales Market Share by Type (2017-2028)
Figure 46. Europe Induced Pluripotent Stem Cells Production Revenue Market Share by Type (2017-2028)
Figure 47. Europe Induced Pluripotent Stem Cells Production Sales Market Share by Application (2017-2028)
Figure 48. Europe Induced Pluripotent Stem Cells Production Revenue Market Share by Application (2017-2028)
Figure 49. Europe Induced Pluripotent Stem Cells Production Sales Share by Country (2017-2028)
Figure 50. Europe Induced Pluripotent Stem Cells Production Revenue Share by Country (2017-2028)
Figure 51. Germany Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 52. France Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 53. U.K. Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 54. Italy Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 55. Russia Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 56. Asia Pacific Induced Pluripotent Stem Cells Production Sales Market Share by Type (2017-2028)
Figure 57. Asia Pacific Induced Pluripotent Stem Cells Production Revenue Market Share by Type (2017-2028)
Figure 58. Asia Pacific Induced Pluripotent Stem Cells Production Sales Market Share by Application (2017-2028)
Figure 59. Asia Pacific Induced Pluripotent Stem Cells Production Revenue Market Share by Application (2017-2028)
Figure 60. Asia Pacific Induced Pluripotent Stem Cells Production Sales Share by Region (2017-2028)
Figure 61. Asia Pacific Induced Pluripotent Stem Cells Production Revenue Share by Region (2017-2028)
Figure 62. China Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 63. Japan Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 64. South Korea Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 65. India Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 66. Australia Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 67. China Taiwan Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 68. Indonesia Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 69. Thailand Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 70. Malaysia Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 71. Latin America Induced Pluripotent Stem Cells Production Sales Market Share by Type (2017-2028)
Figure 72. Latin America Induced Pluripotent Stem Cells Production Revenue Market Share by Type (2017-2028)
Figure 73. Latin America Induced Pluripotent Stem Cells Production Sales Market Share by Application (2017-2028)
Figure 74. Latin America Induced Pluripotent Stem Cells Production Revenue Market Share by Application (2017-2028)
Figure 75. Latin America Induced Pluripotent Stem Cells Production Sales Share by Country (2017-2028)
Figure 76. Latin America Induced Pluripotent Stem Cells Production Revenue Share by Country (2017-2028)
Figure 77. Mexico Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 78. Brazil Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 79. Argentina Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 80. Middle East and Africa Induced Pluripotent Stem Cells Production Sales Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Induced Pluripotent Stem Cells Production Revenue Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Induced Pluripotent Stem Cells Production Sales Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Induced Pluripotent Stem Cells Production Revenue Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Induced Pluripotent Stem Cells Production Sales Share by Country (2017-2028)
Figure 85. Middle East and Africa Induced Pluripotent Stem Cells Production Revenue Share by Country (2017-2028)
Figure 86. Turkey Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 87. Saudi Arabia Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 88. UAE Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 89. Induced Pluripotent Stem Cells Production Value Chain
Figure 90. Induced Pluripotent Stem Cells Production Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 人工多能性幹細胞製造装置の世界市場インサイト・予測(~2028年)(Global Induced Pluripotent Stem Cells Production Market Insights and Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆